Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SLC45A3
REST API REST API
Homo sapiens
SLC45A3 is differentially expressed in 138 experiments: 77 organism parts: prostate, spinal cord, ... (75 more);, 53 disease states: normal, adrenocortical carcinoma, ... (51 more);, 41 cell types 223 cell lines 16 compound treatments and 46 other conditions.
Synonyms PCANAP8, PCANAP6, PCANAP2, prostein, IPCA-8, IPCA-6, IPCA-2
Orthologs SLC45A3 (Bos taurus)   Slc45a3 (Rattus norvegicus)   CG41343 (Drosophila melanogaster)   CG4484 (Drosophila melanogaster)   Slc45a3 (Mus musculus)   SLC45A3 (Gallus gallus)   slc45a3 (Danio rerio)   CG41087 (Drosophila melanogaster)   slc45a3 (Xenopus laevis)   SLC45A3 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term membrane, integral to membrane, transmembrane transport
InterPro Term MFS
UniProt Accession Q96JT2, Q658X7, A8K2U9
Search EB-eye ENSG00000158715
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-803, E-GEOD-6573, E-GEOD-6919, E-GEOD-3526, ... (14 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-14464, E-GEOD-19639, E-GEOD-24147, E-GEOD-19480, ... (17 experiments)

Factor Value U/D Experiments
A549
2
 E-GEOD-6013, E-GEOD-3202
DU145
2
 E-GEOD-17482, E-GEOD-20089
LNCaP
2
 E-GEOD-14990, E-GEOD-14464
MCF-7
2
 E-GEOD-5823, E-GEOD-19639
MOLT16
1
 E-MTAB-37
SKNEP1
1
 E-MTAB-37
217 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-22529, E-AFMX-5, E-GEOD-20193, E-GEOD-21668, ... (21 experiments)

Factor Value U/D Experiments
fibroblast
1
 E-GEOD-26672
plasmablast
1
 E-MEXP-2360
iPS cells from episomal vectors (Defined Factor)
1
 E-GEOD-20033
kidney cell
1
 E-MEXP-1216
CD326negCD56+ cell
1
 E-GEOD-21668
parental foreskin cells
1
 E-GEOD-20033
35 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-22529, E-GEOD-22148, E-GEOD-16363, E-GEOD-8977, ... (25 experiments)

Factor Value U/D Experiments
benign prostatic hyperplasia
2
 E-MEXP-2034, E-GEOD-7307
prostate carcinoma
2
 E-GEOD-7307, E-MEXP-2034
colorectal carcinoma
1
 E-MTAB-37
cMCL (conventional mantle cell lymphoma)
1
 E-GEOD-16455
monoclonal gammopathy of uncertain significance
1
 E-MTAB-372
sarcoma
1
 E-MTAB-37
47 more value(s).


Compound treatment

studied in E-GEOD-20719, E-GEOD-3284, E-TABM-782, E-GEOD-6400, E-MEXP-2241, ... (9 experiments)

Factor Value U/D Experiments
estradiol
1
 E-GEOD-20081
actinomycin D
1
1
 E-GEOD-6400
unknown
1
 E-GEOD-7307
mannitol
1
 E-GEOD-6400
sapphyrin PCI-2050
1
 E-GEOD-6400
Cxcl12
1
1
 E-GEOD-7307
10 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
93
1
1
 E-GEOD-3494


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21589, E-GEOD-16363, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-4667

Dfs follow up
studied in E-GEOD-22541

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-TABM-26, E-GEOD-22148, E-GEOD-21138, ... (6 experiments)

Estrogen receptor status
studied in E-GEOD-6532

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7011, E-GEOD-7578, E-GEOD-20847, E-MTAB-108

Genotype
studied in E-TABM-1029, E-GEOD-3494, E-GEOD-17476, E-MEXP-421, E-MEXP-1403 ... (5 experiments)

Growth condition
studied in E-MEXP-1103, E-MEXP-1741, E-MEXP-2146

Histology
studied in E-TABM-234, E-TABM-276

Individual
studied in E-MTAB-197, E-TABM-325, E-TABM-176, E-MEXP-1290, E-GEOD-19330, ... (20 experiments)

Infection
studied in E-GEOD-12254, E-MEXP-561

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-22056, E-GEOD-12662

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism status
studied in E-GEOD-19188

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-19703, E-GEOD-17636, E-MEXP-1403

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246

RNAi
studied in E-MEXP-2115, E-MEXP-1857, E-MEXP-1315

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400, E-GEOD-18995

Sex
studied in E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-11886, E-GEOD-11428

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Test result
studied in E-TABM-276

Tumor grading
studied in E-GEOD-4922

Processing time: 0.297 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM